The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 346:1243-1245 April 18, 2002 Number 16
NextNext

Macrolide-Resistant Group A Streptococcus — Now in the United States

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Martin, J. M.
-PubMed Citation
Too often antibiotics, remarkable therapies that can cure deadly and disabling infections, are used to satisfy patients' needs rather than out of clinical necessity. This practice translates into the excessive use of antibiotics for acute respiratory tract infections everywhere in the world, including the United States.1

Group A streptococcus is a common bacterial pathogen that causes tonsillitis and skin infections, such as erysipelas and impetigo, as well as serious, life-threatening septic infections and suppurative and nonsuppurative complications. The macrolide antibiotics, such as erythromycin, azithromycin, clarithromycin, and roxithromycin, are usually effective against these streptococci and are commonly used in the treatment . . . [Full Text of this Article]

References


Related Letters:

Erythromycin-Resistant Group A Streptococci
Linder J. A., Stafford R. S., Shulman S. T., Tanz R., Kabat W., Martin J. M., Green M., Wald E. R.
Extract | Full Text | PDF  
N Engl J Med 2002; 347:614-615, Aug 22, 2002. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.